3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
46
Lymphoma, Large B-Cell, Diffuse
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lung Neoplasms
21
Leukemia, Myeloid, Acute
20
Burkitt Lymphoma
18
Hodgkin Disease
15
Recurrence
14
Lymphoma, Non-Hodgkin
14
Lymphoma
14
Carcinoma, Non-Small-Cell Lung
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Neuroblastoma
10
Lymphoma, Mantle-Cell
10
Lymphoma, B-Cell
10
Leukemia
10
Medulloblastoma
8
Neoplasms, Germ Cell and Embryonal
7
Neoplasms
7
Lymphoma, Follicular
7
Multiple Myeloma
6
Lymphoma, T-Cell
6
Brain Neoplasms
6
Sarcoma, Ewing
5
Retinoblastoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Immunoblastic Lymphadenopathy
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Interventions
Doxorubicin
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
CTLA-4 Antigen
3
Biopsy
3
cabozantinib
2
Ifosfamide
2
tremelimumab
1
talimogene laherparepvec
1
regorafenib
1
peposertib
1
pazopanib
1
olaratumab
1
liposomal doxorubicin
1
futibatinib
1
fludarabine
1
eribulin
1
durvalumab
1
avelumab
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Standard of Care
1
Quality of Life
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Etoposide
×
1 year
×
Clear all
No trials found.